1. Fibrinolytic activity was determined by a balance between tissue plasminogen activator and plasminogen activator inhibitor-1.

2. The appearance of serine proteases such as thrombin, tissue plasminogen activator and plasmin in the CNS have come under increasing scrutiny.

3. NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets.

4. Intravenous administration of recombinant tissue plasminogen activator remains the most beneficial proven intervention for emergency treatment of stroke.

5. Objective To observe the effect of recombinant tissue plasminogen activator in the treatment of acute myocardial infarction.

6. According to reports, Nattokinase has plasmin-like bio-characteristic that lyses fibrin directly[sentencedict .com], or increases activity of pro-urokinase and t-PA (Tissue Plasminogen Activator).

7. Objective To study the changes of the endothelial tissue plasminogen activator reserve capacity in patients with acute coronary syndromes.

8. The screening of human tissue plasminogen activator recombinant plasmid showed that the two methods can recognize the positive colones quickly and correctly.

9. Neither study, however, directly measured the ascitic concentrations of tissue plasminogen activator.

10. Lysis of the hematoma with various enzymes, such as urokinase or tissue plasminogen activator (TPA), and drainage of liquefied clot has become an alternative.

11. But Dr. Marian LaMonte, co-director of the Brain Attack Team, began intravenously administering a drug called tissue plasminogen activator (t-PA).

12. Objective To investigate the anticoagulative and fibrinolytic effects of lumbrokinase and their relation to tissue plasminogen activator (t-PA).

13. Objective: To evaluate the efficacy and safety of recombinant tissue plasminogen activator in hyper acute cerebral infarction.

14. This was accompanied by severe disruption of the blood–brain barrier and an increased rate of intracerebral hemorrhages after tissue plasminogen activator treatment.

15. Should the patients with middlecerebralarteryocclusion of transient ischemic attack be treated with intravenous tissue plasminogen activator?

16. The thrombolytic effect was compared between urokinase (UK) and human tissue plasminogen activator (t-PA) in rabbits with experimental iliofemoral artery thrombus.